Short Interest in Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Decreases By 67.3%

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) was the target of a significant decline in short interest during the month of April. As of April 30th, there was short interest totaling 1,789 shares, a decline of 67.3% from the April 15th total of 5,479 shares. Based on an average daily trading volume, of 102,108 shares, the days-to-cover ratio is presently 0.0 days.

Tevogen Bio Price Performance

Tevogen Bio stock opened at $0.04 on Friday. The business’s fifty day simple moving average is $0.03 and its two-hundred day simple moving average is $0.04. Tevogen Bio has a 12 month low of $0.03 and a 12 month high of $0.08.

About Tevogen Bio

Tevogen Bio is a clinical-stage biotechnology company focused on developing allogeneic T cell receptor (TCR)-based immunotherapies for the treatment of cancer and infectious diseases. Leveraging a proprietary platform of engineered T cells, the company aims to deliver off-the-shelf cellular products that can recognize and eliminate disease-specific antigens without the need for patient-matched cell manufacturing.

The company’s pipeline encompasses programs targeting chronic viral infections, including hepatitis B virus and SARS-CoV-2, as well as cytomegalovirus, alongside oncology indications such as solid and hematological tumors.